Safe antileukemia drug, SAL

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514557, 514717, A61K 3155, A61K 3119, A61K 31075

Patent

active

046753184

ABSTRACT:
A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.

REFERENCES:
patent: 4152333 (1979-05-01), Mikolajczak
patent: 4206221 (1980-06-01), Miller
Merck Index, 10th ed., #6705 and 4284, 1983.
A translation of an article entitled Clinical Observations on Forty Cases Nonlymphatic Leukemia with Treatment of Homoharringtonine and Harringtonine, by L. H. Lou and C. H. Chen, Journal of Chinese Internal Medicine 3:162-164, 1978.
Original copies of Journal of Chinese Internal Medicine 3:162-164, 1978.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Safe antileukemia drug, SAL does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Safe antileukemia drug, SAL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Safe antileukemia drug, SAL will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-721354

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.